Article
The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma risk.
Cancer medicine - 1 May 2016
Becker Jessica, May Andrea, Gerges Christian, Anders Mario, Schmidt Claudia, Veits Lothar, Noder Tania, Mayershofer Rupert, Kreuser Nicole, Manner Hendrik, Venerito Marino, Hofer Jan-Hinnerk, Lyros Orestis, Ahlbrand Constantin J, Arras Michael, Hofer Sebastian, Heinrichs Sophie K M, Weise Katharina, Hess Timo, Böhmer Anne C, Kosiol Nils, Kiesslich Ralf, Izbicki Jakob R, Hölscher Arnulf H, Bollschweiler Elfriede, Malfertheiner Peter, Lang Hauke, Moehler Markus, Lorenz Dietmar, Ott Katja, Schmidt Thomas, Nöthen Markus M, Hackelsberger Andreas, Schumacher Brigitte, Pech Oliver, Vashist Yogesh, Vieth Michael, Weismüller Josef, Knapp Michael, Neuhaus Horst, Rösch Thomas, Ell Christian, Gockel Ines, Schumacher Johannes
Abstract excerpt
Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) represent two stages within the esophagitis-metaplasia-dysplasia-adenocarcinoma sequence. Previously genetic risk factors have been identified that confer risk to BE and EAC development. However, to which extent the genetic variants confer risk to different stages of the BE/EAC sequence remains mainly unknown. In this study we analyzed three most...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
